Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Net Margin (2016 - 2026)

Usana Health Sciences has reported Net Margin over the past 17 years, most recently at 2.78% for Q2 2026.

  • Quarterly Net Margin fell 94.0% to 2.78% in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 0.99% through Apr 2026, down 299.0% year-over-year, with the annual reading at 1.24% for FY2026, 368.0% down from the prior year.
  • Net Margin was 2.78% for Q2 2026 at Usana Health Sciences, up from 0.71% in the prior quarter.
  • Over five years, Net Margin peaked at 8.23% in Q2 2022 and troughed at 3.12% in Q3 2025.
  • The 5-year median for Net Margin is 5.46% (2023), against an average of 4.85%.
  • Year-over-year, Net Margin surged 197bps in 2023 and then plummeted -842bps in 2025.
  • A 5-year view of Net Margin shows it stood at 5.61% in 2022, then skyrocketed by 35bps to 7.58% in 2023, then plummeted by -72bps to 2.1% in 2024, then plummeted by -249bps to 3.12% in 2025, then soared by 189bps to 2.78% in 2026.
  • Per Business Quant, the three most recent readings for USNA's Net Margin are 2.78% (Q2 2026), 0.71% (Q1 2026), and 3.12% (Q3 2025).